His work focuses on how microbial ecosystems interact with human physiology, including: Gut barrier function and intestinal permeability Mucus-associated microbiota (Akkermansia-related systems) Oralgut microbiome axis Short-chain fatty acids (SCFAs) and metabolic signaling Circadian rhythmmicrobiome interactions Clinical Research Contributions He has contributed to multiple clinical-stage microbiome programs, supporting bacterial strain discovery, optimization, and formulation design across different therapeutic areas, including: Active Ulcerative Colitis (Inflammatory Bowel Disease) Hyperoxaluria (Oxalate Metabolism Disorder) Microbiome-driven gut health and inflammatory conditions These studies were part of broader clinical development programs evaluating microbiome-based approaches
DSIP entered the literature through delta-EEG enhancement in animal models, and the preclinical sleep work that followed examined wakefulness and sleep patterns in species including the cat (PMID 3620931)
The levels of HbA1c, dyslipidemia, BW and BP are several of the risk factors for the progression of atherosclerosis and CVD in patients with T2DM
Perkins says
Product Name Bacteriostatic Water for Injection Trade Name Bactsyl Available Strength 0.9% benzyl alcohol Packing 1 ml, 2 ml, 5 ml, 10 ml, 20 ml, 30 ml Therapeutic Use Diluent/Solvent for reconstitution of injections